Akrivis Technologies, LLC

UEI: FFCTS1CWUD37
CAGE: 5EA80
Primary NAICS: 325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration: Expired Dec 2, 2018

Company facts

Self-certified in SAM.gov: Minority Owned Business

Self Certified Small Disadvantaged Business

For Profit Organization

Limited Liability Company

Black American Owned
Entity structure: Other
Other NAICS codes in SAM.gov: 325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration date: Apr 9, 2009
Website: akrivis.com
Employees: 1-10
Estimated annual revenue: $0-$1M
Industry: Industrials

Capital Goods

Industrial Conglomerates

Industrials & Manufacturing
SIC code: 38 Instruments & Related Products
Profiles: LinkedIn

X

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated Mar 3, 2019.

Contract awards

Award	Agency	Obligated	Awarded
Sbir phase 2 topic 314 HHSN261201500054C	National Cancer Institute (NIH)	$299,920	Sep 22, 2015
Pre-targeting of cancer stem cells and subsequent delivery of high payload of STAT3 HHSN261201400026C	National Cancer Institute (NIH)	$224,452	Sep 12, 2014

Quick answers

Is Akrivis Technologies, LLC registered in SAM.gov?

Akrivis Technologies, LLC's SAM.gov registration expired on December 2, 2018.

What is Akrivis Technologies, LLC's most recent federal award?

Akrivis Technologies, LLC's most recent federal contract award is Sbir phase 2 topic 314 (HHSN261201500054C), from National Cancer Institute (NIH), on September 22, 2015.

On GovTribe

See Akrivis Technologies, LLC's full federal record

Federal contract awards
Funding analysis by agency, NAICS and set-aside
Similar vendors

Try for free Login